Evidence-based Weight Loss
EverLean provides medically supervised access to GLP-1 and dual-pathway therapies. Secure your treatment, complete your clinical review, and begin your transformation.
Prescription Policy
To ensure clinical safety, payment is required to initiate your medical review. If our clinicians determine you are not suitable, a 100% refund is processed immediately.
Mounjaro
The first treatment of its kind to target two hunger receptors, often resulting in more significant appetite suppression.
Wegovy
The globally recognized leader in weight management. Proven results through a steady, well-tolerated clinical pathway.
Our Suitability Guarantee
We only charge for treatments we can safely provide. If our doctor finds that you aren't a clinical match for the medication, your payment is automatically refunded. Your health—and your trust—come first.
Compare Treatments
Select a treatment to view available doses.
| Feature | Mounjaro® | Wegovy® |
|---|---|---|
| Active Ingredient |
Tirzepatide Dual-action (GIP & GLP-1) |
Semaglutide Single-action (GLP-1) |
| How it Works | Mimics two metabolic hormones to regulate appetite and blood sugar. | Mimics one metabolic hormone to increase fullness and slow digestion. |
| Clinical Weight Loss | Up to 25% body weight reduction | Up to 15-20% body weight reduction |
| Administration | Once-weekly KwikPen® injection | Once-weekly injection pen |
| Food Noise | ✓ High effectiveness in silencing cravings | ✓ Effective appetite regulation |